Colombian Flower Is Now Available To Australian Patients Through Strategic Partnership Between Clever Leaves And Australian Natural Therapeutics Group
TOCANCIPÁ, Colombia and SYDNEY, Australia, July 26, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that its Colombian flower is now available to patients in Australia through a partnership with Australian Natural Therapeutics Group (“ANTG”), one of the leading medicinal cannabis providers in Australia. The products are available to medical patients in Australia under ANTG’s “Global Selects” brand portfolio.
Related news for (CLVRW)
- Clever Leaves Announces Voluntary Delisting and SEC Deregistration
- Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
- Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia
- Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
- Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)